{"id":8389,"date":"2021-12-16T13:26:58","date_gmt":"2021-12-16T18:26:58","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/lisiraglide-cas-320367-13-3-je-agonista-receptoru-glukagonu-podobneho-peptidu-1-glp-1\/"},"modified":"2021-12-16T13:26:58","modified_gmt":"2021-12-16T18:26:58","slug":"lisiraglide-cas-320367-13-3-je-agonista-receptoru-glukagonu-podobneho-peptidu-1-glp-1","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/cs\/product\/lisiraglide-cas-320367-13-3-je-agonista-receptoru-glukagonu-podobneho-peptidu-1-glp-1\/","title":{"rendered":"Lisiraglide CAS 320367-13-3 je agonista receptoru glukagonu podobn\u00e9ho peptidu-1 (GLP-1)"},"content":{"rendered":"<h2><strong>Lisiraglide CAS 320367-13-3 je agonista receptoru glukagonu podobn\u00e9ho peptidu-1 (GLP-1)<\/strong><\/h2>\n<p>N\u00e1zev produktu: Lixisenatid<br \/>\nSynonyma: Lixisenatid, &gt;98%;lixisenatid;Lixisenatid|Lixisenatidacet\u00e1t;Lixisenatidacet\u00e1t;Lixisenatid USP\/EP\/BP<br \/>\nCAS: 320367-13-3-3255NHO4MF: C667<br \/>\nMW: 4858,53<br \/>\nEINECS:<br \/>\nKategorie produkt\u016f:<br \/>\nMol File: 320367-13-3.mol<\/p>\n<p>Lisiraglide je glukagonu podobn\u00fd peptid-1 (GLP-1) agonista receptoru, hormon, kter\u00fd pom\u00e1h\u00e1 normalizovat hladinu cukru v krvi. Bezpe\u010dnost a \u00fa\u010dinnost l\u00e9ku byla hodnocena v 10 klinick\u00fdch studi\u00edch, do kter\u00fdch bylo za\u0159azeno celkem 5 400 pacient\u016f s diabetem 2. typu. V t\u011bchto studi\u00edch byl lisiramid hodnocen jak v monoterapii, tak v kombinaci s jin\u00fdmi l\u00e9ky na diabetes schv\u00e1len\u00fdmi FDA, v\u010detn\u011b metforminu, deriv\u00e1t\u016f sulfonylurey, pioglitazonu a baz\u00e1ln\u00edho inzul\u00ednu. V t\u011bchto studi\u00edch pou\u017eit\u00ed lisiramidu zlep\u0161ilo hladiny glykovan\u00e9ho hemoglobinu (ukazatel hladiny gluk\u00f3zy v krvi). Krom\u011b toho bylo ve studii Cardiovascular Outcomes Trial v\u00edce ne\u017e 6 000 pacient\u016f s diabetem 2. typu s rizikem aterosklerotick\u00e9ho kardiovaskul\u00e1rn\u00edho onemocn\u011bn\u00ed l\u00e9\u010deno lisiramidem nebo placebem. Pou\u017eit\u00ed lisiramidu u t\u011bchto pacient\u016f nezv\u00fd\u0161ilo riziko ne\u017e\u00e1douc\u00edch kardiovaskul\u00e1rn\u00edch p\u0159\u00edhod. Lisiragid by se nem\u011bl pou\u017e\u00edvat k l\u00e9\u010db\u011b pacient\u016f s diabetem 1. typu nebo pacient\u016f se zv\u00fd\u0161enou hladinou keton\u016f nebo mo\u010di v krvi (diabetick\u00e1 ketoacid\u00f3za). Nejb\u011b\u017en\u011bj\u0161\u00ed vedlej\u0161\u00ed \u00fa\u010dinky spojen\u00e9 s lisiramidem jsou nevolnost, zvracen\u00ed, bolest hlavy, pr\u016fjem a z\u00e1vrat\u011b. Hypoglyk\u00e9mie je dal\u0161\u00edm \u010dast\u00fdm vedlej\u0161\u00edm \u00fa\u010dinkem u pacient\u016f l\u00e9\u010den\u00fdch lisiramidem a jin\u00fdmi antidiabetiky, jako jsou deriv\u00e1ty sulfonylmo\u010doviny a\/nebo baz\u00e1ln\u00ed plodina. Krom\u011b toho byly v klinick\u00fdch studi\u00edch s Lisiragibem hl\u00e1\u0161eny z\u00e1va\u017en\u00e9 reakce z p\u0159ecitliv\u011blosti (v\u010detn\u011b p\u0159ecitliv\u011blosti).<\/p>\n<p>Lixisenatid je l\u00e9k, kter\u00fd se v sou\u010dasnosti pou\u017e\u00edv\u00e1 k l\u00e9\u010db\u011b diabetu a je tak\u00e9 agonistou receptoru GLP-1. Lixisenatid (Lyxumia) byl schv\u00e1len k uveden\u00ed na trh v Evrop\u011b v roce 2013 a jde o injek\u010dn\u00ed diabetickou l\u00e9\u010dbu zalo\u017eenou na lixisenatidu, kter\u00e1 se pod\u00e1v\u00e1 jednou denn\u011b spole\u010dn\u011b s dal\u0161\u00edmi l\u00e9ky nebo inzul\u00ednem pacient\u016fm, jejich\u017e hladinu gluk\u00f3zy v krvi lze kontrolovat pouze l\u00e9ky.&lt; &amp;&gt;<br \/>\n <strong>Pozn\u00e1mka k Lisiraglide CAS 320367-13-3<\/strong><br \/>\nPouze pro v\u00fdzkumn\u00e9 \u00fa\u010dely, ne pro hum\u00e1nn\u00ed pou\u017eit\u00ed<\/p>\n","protected":false},"excerpt":{"rendered":"<p>N\u00e1zev produktu: Lixisenatid<br \/>\nAcetate;Lixisenatid USP\/EP\/BP<br \/>\nCAS: 320367-13-3<br \/>\nMF: C215H347N61O65S<br \/>\nMW: 4858,53<br \/>\nMol Soubor: 320367-13-3.mol<\/p>\n","protected":false},"featured_media":2097,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[339],"product_tag":[1262],"class_list":{"0":"post-8389","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-peptid-diabetu","7":"product_tag-lisiraglide-cas-320367-13-3-is-a-glucagon-like-peptide-1-glp-1-receptor-agonist-cs","8":"desktop-align-left","9":"tablet-align-left","10":"mobile-align-left","12":"first","13":"instock","14":"shipping-taxable","15":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/cs\/wp-json\/wp\/v2\/product\/8389","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/cs\/wp-json\/wp\/v2\/comments?post=8389"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/cs\/wp-json\/wp\/v2\/media\/2097"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/cs\/wp-json\/wp\/v2\/media?parent=8389"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/cs\/wp-json\/wp\/v2\/product_brand?post=8389"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/cs\/wp-json\/wp\/v2\/product_cat?post=8389"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/cs\/wp-json\/wp\/v2\/product_tag?post=8389"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}